FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults

The US Food and Drug Administration's independent advisers concluded that Paxlovid is not associated with Covid-19 rebound, in which people test positive or see their symptoms return after they finish the five-day course of the drug.

Advisers to the US Food and Drug Administration voted 16-1 on Thursday in support of full approval of Paxlovid, stating that the benefits outweigh the risks of the drug for treatment of mild to moderate Covid-19 in adults who are at high risk for severe disease, including hospitalization and death.

Before the antiviral medication is fully approved, the FDA -- which typically follows the recommendations of its independent advisory committee -- must conduct its own review. That's expected to wrap up in May.

Forecast Update

Snow Showers End Early, Windy & Chilly Today

April 1, 2023 @ 5:00 am

THIS WEEKEND: The snow showers will taper early today, with decreasing clouds through the day. However, it will be chilly and blustery with hi…

Plan my day

Mix of sun and clouds. Highs in the mid 40s and lows in the upper 20s.
Mainly clear early, then a few clouds later on. Low 27F with temps rising to near freezing. W winds shifting to SSE at 10 to 15 mph.
Windy with clouds. Highs in the upper 50s and lows in the mid 30s.